62741 news 1287446400 1475896066 <![CDATA[GA. in Stem Cell Focus]]> It was a matter of horrible happenstance that brought the first human trial involving embryonic stem cells to Atlanta this month.

Teams at both Atlanta’s Shepherd Center and Northwestern University in Chicago were standing by to begin the historic trial, each awaiting a newly injured patient. Sometime in the 14 days before Oct. 8, someone, presumably in the South, suffered a paralyzing spine injury, signed the papers and became Patient A.

The procedure occurred at Piedmont Hospital, which adjoins Shepherd. The patient’s name, age and sex are unknown. The news — abhorrent in some quarters, thrilling in others — immediately spread worldwide, seemingly thrusting Atlanta into the biomedical spotlight.

But the choice of an Atlanta institution to play a part in the landmark study was no accident. A confluence of factors has turned Georgia into a top-tier state for biotech research and development. There are learning centers such as Georgia Tech, the University of Georgia and Emory University, a pro-business climate that includes top-notch hospitals and the utility of Hartsfield-Jackson International Airport, among others.

Read Full Article

]]> 2010-10-17T00:00:00-04:00 It was a matter of horrible happenstance that brought the first human trial involving embryonic stem cells to Atlanta this month. Teams at both Atlanta’s Shepherd Center and Northwestern University in Chicago were standing by to begin the historic trial, each awaiting a newly injured patient. Sometime in the 14 days before Oct. 8, someone, presumably in the South, suffered a paralyzing spine injury, signed the papers and became Patient A.

]]> 66537 image <![CDATA[Embryonic stem cells are a blank slate having the potential to turn into cells that build parts of the body. Their use is also among the nation's -- and Georgia's -- most hot-button political issues.]]> 192571 image/jpeg Floyd Wood
IBB
Contact Floyd Wood

]]> 1292 129 139 141 134 145 149 135 150 1292 109 1487 248 167413